The National Science and Technology Council publishes a
Framework for Nucleic Acid Synthesis Screening, which
incorporates and supplements portions of the Screening Framework
Guidance for Providers and Users of Synthetic Nucleic Acids as
published by the U.S. Department of Health and Human Services.
Instance attests that it adheres to each of the criteria in the
Framework for Nucleic Acid Synthesis Screening. If the Company
ceases to adhere to the framework, it will notify, within 72
hours, any federally funded customers and federal funding
agencies to which it previously submitted an attestation.
For additional information, please contact hello@instance.bio